Skip to NavigationSkip to content

News

Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in...
The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development collaboration...
AstraZeneca is celebrating alongside partner MSD with the reveal of new data on the use of Lynparza in the first-line treatment of BRCA-mutated...
Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory panel,...
Roivant has announced it is to undergo a major restructure and launch two new business units alongside a new startup – a move which will also see...
Prominent industry player Boehringer Ingelheim has unveiled plans to invest €230 million into the construction of a new Biologicals Development...
The NHS’s 70th birthday is again marked as a bittersweet one as a new report from the Nuffield Trust highlights the service’s deteriorating ability...
Pfizer has confirmed that Ibrance, in combination with AstraZenenca’s Faslosdex, failed to meet its Phase 3 secondary endpoint of overall survival...
Sanofi has unveiled new data on its diabetes therapy Toujeo, demonstrating that it proved non-inferior to insulin degludec in adult patients with...
UK biotech GW Pharmaceuticals has announced that its oral cannabidiol solution Epidiolex has been awarded marketing approval in the US by the FDA...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches